SARS COv-2

Research

Compounds halt SARS-CoV-2 replication by targeting key viral enzyme

Four promising antiviral drug candidates identified and analyzed in preclinical study Date: July 6, 2020 Source 1: University of South Florida (USF Health) Source 2: www.sciencedaily.com Summary: New research identifies several existing compounds that block replication of the COVID-19 virus (SARS-CoV-2) within human cells grown in the laboratory. The inhibitors all demonstrated potent chemical and […]

Research

Controlled human infection models and SARS-CoV-2 vaccine development

Date: July 2, 2020 Source 1: Walter Reed Army Institute of Research Source 2: www.sciencedaily.com Summary: Infecting volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls and is unlikely to advance the current slate of vaccines in advanced development, argues a group of infectious disease

Research

Researchers identify potent antibody cocktail to treat COVID-19

Publication highlights process for yielding array of human antibodies that target protein on virus Date: June 16, 2020 Source 1: University of Maryland School of Medicine Source 2: www.sciencedaily.com Summary: Researchers evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against

Scroll to Top